Medical Program-Wide Activities

Abstract

The Army Medical Command receives funding for research infrastructure management support at select continental United States (CONUS) and outside the continental US (OCONUS) laboratories and clinical trial sites; work is done in collaboration with DoD Military Treatment Facilities (MTFs). This funding does not fund research. It funds the infrastructure support enabling research scientists at these laboratories to conduct bio-surveillance and early-to-late-stage clinical investigations into biologics, drugs, protectants, device technologies, and knowledge products. Areas of research interest include the treatment/prevention/diagnosis of polytrauma (multiple traumatic injuries), infectious diseases, psychological health, traumatic brain injury, and military training injuries. The funding provides for the sustainment of technical subject matter expertise, independent of the number of assigned projects, and the costs related to the initial outfitting and transition (IO&T) of research, development, test and evaluation (RDT&E) medical laboratories funded under multi-year military construction (MILCON) projects. These IO&T funds are designated as appropriations other than MILCON. The Office of the Assistant Secretary of Defense for Health Affairs (Force Health Protection & Readiness) receives funds to provide management support for research projects at Pacific Joint Information Technology Center (P-JITC). For the Navy Bureau of Medicine and Surgery, this program element includes facility operational funding for the Medical Biological Defense research sub-function of the Naval Medical Research Center (NMRC) Biological Defense Research Directorate (BDRD). The program mission is mandated by the Joint Requirements Office for Chemical, Biological, Radiological, and Nuclear Defense (JRO-CBRND) baseline capabilities assessment of chemical and biological passive defense. The primary function is research on countermeasures to biological threat agents, development of assays to detect biological threat agents, and bioforensic analysis of biological threat agents.

Open PDF

Document Details

Document Type
R2 Budgetary Justification
Publication Date
Oct 01, 2016
Source ID
0606105HP_2_0130_PB_2016
Change Summary Explanation
FY 2014: Realignment from Defense Health Program, Research, Development, Test and Evaluation (DHP RDT&E), PE 0606105-Medical Program-Wide Activities (-$4.291 million) to DHP RDT&E PE 0605502-Small Business Innovation Research (SBIR) Program (+$4.291 million). FY 2015: Congressional Special Interest (CSI) Additions to DHP RDT&E, PE 0606105-Medical Program-Wide Activities (+$5.967 million). FY 2016: Transfer between DHP Budget Activities of the Pacific-Based Joint Information Technology Center-Maui (JITC-Maui) (-$5.174 million). FY 2016: Realignment adjustment to DHP RDT&E, PE 0606105-Medical Program-Wide Activities (+$2.698 million).
Service Agency Name
Defense Health Program

Tags

DTIC Thesaurus Topics

  • Acquisition
  • Biological Products
  • Biomedical Research
  • Brain Injuries
  • Chemical Warfare Agents
  • Diseases And Disorders
  • Governments
  • Health
  • Infectious Diseases
  • Information Systems
  • Medical Laboratories
  • Military Medicine
  • Military Personnel
  • Military Training
  • Personnel Management
  • Test And Evaluation
  • United States

Readers

  • Critical Infrastructure Protection in CBRN and WMD Threats.
  • Medical or Health Care Field.

Related Documents